Publication Highlights

december 2021

infection & immunobiology

CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in MS

October 2021

infection & immunobiology

COVID-19 vaccine response in people with multiple sclerosis

Summer 2021


Immunogenicity of biologics used in the treatment of moderate to severe psoriasis

summer 2021


Immunogenicity of biologics used in the treatment of inflammatory bowel disease: A review

summer 2021

immunotherapy failure

Anti-drug antibodies to antibody-based therapeutics in multiple sclerosis

July 2020

infection & immunobiology

Mapping the T cell response to COVID-19

june 2020

Neurology & Neuroscience

Detecting and predicting neutralization of Alemtuzumab responses in Multiple Sclerosis.

may 2020

infection & immunoBIOLOGY

The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic